Prevalence, age and gender features of chronic kidney disease in patients with diabetes mellitus

Cover Page

Cite item

Full Text

Abstract

Aim. To study the prevalence, age and gender characteristics of chronic kidney disease (CKD) in patients with diabetes mellitus (DM).

Materials and methods. In a case-control study, clinical and laboratory data were analyzed in 683 patients with DM (4.6% of patients with type 1 DM and 95.4% with type 2 DM) and kidney damage. The indicators of anthropometry, hemodynamics and biochemistry were studied. The glomerular filtration rate (GFR) was calculated using the CKD-EPI formula.

Results. The proportion of middle-aged and elderly patients with CKD was the most numerous, amounting to 39 and 38%, respectively. At the same time, anemia was more common in young people, and hypercholesterolemia (35.0%), proteinuria (47.5%) and signs of renal failure (45.0%) – in middle-aged patients with CKD. 47.0% study participants had C1 and C2 categories of changes in renal function. Mean levels of systolic blood pressure (BP), the prevalence of proteinuria were statistically significantly higher in women. When evaluating the correlations, we found statistically significant relationships between the calculated GFR and the level of body mass index, systolic BP, venous blood glucose and Hb in the subgroup of men. Among females, a significant relationship between the calculated GFR value was revealed with indicators of systolic and diastolic BP, venous blood glucose and Hb concentration.

Conclusion. Our data indicate the existence of differences in the prevalence of CKD and associated risk factors for the progression of renal failure, depending on gender differences and living conditions of patients. In urban residents, CKD was most often associated with arterial hypertension and renal failure, while overweight, obesity, and proteinuria were significantly more common in rural areas. The incidence of proteinuria and mean levels of systolic BP were significantly higher in females. Further study of the issue under discussion seems promising from the standpoint of a personalized approach and the search for a new preventive strategy to combat both end-stage renal failure and its complications.

About the authors

Ilkhom T. Murkamilov

Akhunbaev Kyrgyz State Medical Academy; Yeltsin Kyrgyz-Russian Slavic University

Author for correspondence.
Email: murkamilov.i@mail.ru
ORCID iD: 0000-0001-8513-9279

д-р мед. наук, доц. каф. факультетской терапии КГМА им. И.К. Ахунбаева, ст. преподаватель ГОУ ВПО КРСУ, председатель правления Общества специалистов по хронической болезни почек Кыргызстана

Kyrgyzstan, Bishkek; Bishkek

Kubanych A. Aitbaev

Research Institute of Molecular Biology and Medicine

Email: murkamilov.i@mail.ru
ORCID iD: 0000-0003-4973-039X

д-р мед. наук, проф., зав. лаб. патологической физиологии НИИ молекулярной биологии и медицины, член правления Общества специалистов по хронической болезни почек Кыргызстана

Kyrgyzstan, Bishkek

Victor V. Fomin

Sechenov First Moscow State Medical University (Sechenov University)

Email: murkamilov.i@mail.ru
ORCID iD: 0000-0002-2682-4417

чл.-кор. РАН, д-р мед. наук., проф., зав. каф. факультетской терапии №1 Института клинической медицины им. Н.В. Склифосовского, проректор по инновационной и клинической деятельности ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)

Russian Federation, Moscow

References

  1. Дедов И.И., Шестакова М.В., Викулова О.К., и др. Сахарный диабет в Российской Федерации: динамика эпидемиологических показателей по данным Федерального регистра сахарного диабета за период 2010–2022 гг. Сахарный диабет. 2023;26(2):104-23 [Dedov II, Shestakova MV, Vikulova OK, et al. Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022. Diabetes mellitus. 2023;26(2):104-23 (in Russian)]. doi: 10.14341/DM13035
  2. Дедов И.И., Шестакова М.В., Майоров А.Ю., и др. Сахарный диабет 2 типа у взрослых. Сахарный диабет. 2020;23(S2):4-102 [Dedov II, Shestakova MV, Mayorov AY, et al. Diabetes mellitus type 2 in adults. Diabetes mellitus. 2020;23(S2):4-102 (in Russian)]. doi: 10.14341/DM23S2
  3. Муркамилов И.Т., Сабиров И.С., Фомин В.В., и др. Современные методы замедления прогрессирования хронической болезни почек при сахарном диабете II типа. Вестник современной клинической медицины. 2020;13(4):76-85 [Murkamilov IT, Sabirov IS, Fomin VV, et al. Modern methods of slowing down the progression of chronic kidney disease in type II diabetes mellitus. The Bulletin of Contemporary Clinical Medicine. 2020;13(4):76-85 (in Russian)]. doi: 10.20969/VSKM.2020.13(4).76-85
  4. Шестакова М.В., Шестакова Е.А., Скляник И.А., Стафеев Ю.С. Ожирение и сахарный диабет – всегда ли вместе? Терапевтический архив. 2022;94(10):1131-5 [Shestakova MV, Shestakova EA, Sklyanik IA, Stafeev IS. Obesity and diabetes – are they always together? Terapevticheskii arkhiv (Ter. Arkh.). 2022;94(10):1131-5 (in Russian)]. doi: 10.26442/00403660.2022.10.201880
  5. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12. doi: 10.7326/0003-4819-150-9-200905050-00006
  6. Маслова О.В., Сунцов Ю.И., Шестакова М.В., и др. Распространенность поражения почек при сахарном диабете 1 и 2 типов в Российской Федерации. Сахарный диабет. 2009;4:47-51 [Maslova OV, Suntsov YuI, Shestakova MV, et al. Prevalence of renal lesions in patients with type 1 and 2 diabetes mellitus in the Russian Federation. Diabetes mellitus. 2009;4:47-51 (in Russian)].
  7. Бобкова И.Н., Щукина А.А., Шестакова М.В. Оценка уровней нефрина и подоцина в моче у больных с сахарным диабетом. Нефрология. 2017;21(2):33-40 [Bobkova IN, Shchukina AA, Shestakova MV. Assessment of nephrin and podocin levels in the urine of patients with diabetes mellitus. Nephrology (Saint-Petersburg). 2017;21(2):33-40 (in Russian)]. doi: 10.24884/1561-6274-2017-21-2-33-40
  8. Ruilope LM, Ortiz A, Lucia A, et al. Prevention of cardiorenal damage: importance of albuminuria. Eur Heart J. 2023;44(13):1112-23. doi: 10.1093/eurheartj/ehac683
  9. Seravalle G, Grassi G. Chapter 5. Renin–angiotensin–aldosterone system and blood pressure regulation. Endocrine Hypertension. Academic Press. 2023:63-75. doi: 10.1016/B978-0-323-96120-2.00002-9
  10. Wu T, Ding L, Andoh V, et al. The mechanism of hyperglycemia-induced renal cell injury in diabetic nephropathy disease: An update. Life. 2023;13(2):539. doi: 10.3390/life13020539
  11. Гуcсаова С.С., Бобкова И.Н., Яшков Ю.И., и др. Изменение метаболических показателей и скорости клубочковой фильтрации у больных морбидным ожирением после бариатрических операций. Терапевтический архив. 2020;92(6):53-9 [Gussaova SS, Bobkova IN, Yashkov YI, et al. Changes in metabolic parameters and glomerular filtration rate in patients with morbid obesity after bariatric surgery. Terapevticheskii arkhiv (Ter. Arkh.) 2020;92(6):53-9 (in Russian)]. doi: 10.26442/00403660.2020.06.000674
  12. Бобкова И.Н., Гуссаова С.С., Ставровская Е.В. Поражение почек при ожирении: варианты течения, механизмы развития. Терапия. 2019;6(32):87-93 [Bobkova IN, Gussaova SS, Stavrovskaya EV. Kidney damage in case of obesity: variants of clinical course, mechanisms of development. Therapy. 2019;6(32):87-93 (in Russian)]. doi: 10.18565/therapy.2019.6.87-93
  13. Lorber D, Reddan D. Clinical characteristics of chronic kidney disease patients with and without diabetes: a subanalysis of the PAERI study. Clin Nephrol. 2006;66(1):11-6. doi: 10.5414/cnp66011
  14. Bonney A, Mayne DJ, Jones BD, et al. Area-Level Socioeconomic Gradients in Overweight and Obesity in a Community-Derived Cohort of Health Service Users – A Cross-Sectional Study. PLoS One. 2015;10(8):e0137261. DOI:10.1371/ journal.pone.0137261
  15. Lindroth M, Lundqvist R, Lilja M, et al. Cardiovascular risk factors differ between rural and urban Sweden: the 2009 Northern Sweden MONICA cohort. BMC Public Health. 2014;14(1):825. doi: 10.1186/1471-2458-14-825

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Age distribution of chronic kidney (CKD) disease patients.

Download (50KB)
3. Fig. 2. Distribution of patients with CKD (n=683) depending on glomerular filtration rate.

Download (29KB)
4. Fig. 3. Age and hemodynamics by sex.

Download (45KB)
5. Fig. 4. Comparative clinical-laboratory profile of patients by sex.

Download (37KB)

Copyright (c) 2023 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies